VigorLife Saw Palmetto
Natural health product licensed in Canada
- Licence holder
- G-Way International Enterprises Inc.
- NPN or DIN-HM
- 80001235
- Status
- Active licence
- Licence date
- 9 January 2006
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | Not specified |
Uses authorised in Canada
Helps to relieve the urologic symptoms associated with benign prostatic hyperplasia. Traditionally used to promote weight gain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking hormone replacement therapy. Consult a health care practitioner prior to use if you are taking birth control medication. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner if you experience gastrointestinal discomfort. If symptoms persist after 6 months, consult a health care practitioner.
- Contre-indications
Do not use if you are pregnant and breastfeeding.
- Effets indésirables connus
None known.
Source
Official Health Canada record, licence 80001235
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.